Raghav Pawan Kumar, Singh Ajay Kumar, Gangenahalli Gurudutta
Division of Stem Cell and Gene Therapy Research, Institute of Nuclear Medicine and Allied Sciences (INMAS), Brigadier S. K. Mazumdar Marg, Timarpur, Delhi, 110054, India.
Division of Stem Cell and Gene Therapy Research, Institute of Nuclear Medicine and Allied Sciences (INMAS), Brigadier S. K. Mazumdar Marg, Timarpur, Delhi, 110054, India.
Mutat Res. 2018 Mar;808:28-38. doi: 10.1016/j.mrfmmm.2018.02.001. Epub 2018 Feb 17.
Several signaling pathways, ligands, and genes that regulate proliferative and self-renewal properties of the Hematopoietic Stem Cells (HSCs) have been studied meticulously. One of the signaling pathways that play a crucial role in the process of hematopoiesis is the Stem Cell Factor (SCF) mediated c-Kit pathway. The c-Kit is a Receptor Tyrosine Kinase (RTK), which is expressed in the cells including HSCs. It undergoes dimerization upon binding with its cognate ligand SCF. As a result, phosphorylation of the Juxtamembrane (JM) domain of c-Kit takes place at Tyr568 and Tyr570 residues. These phosphorylated residues become the docking sites for protein tyrosine phosphatases (PTPs) namely SHP-1 and SHP-2, which in turn cause dephosphorylation and negative regulation of the downstream signaling responsible for the cell proliferation. Interestingly, it has been reported that the mutation of c-Kit at D816V makes it independent of SCF stimulation and SHP-1/SHP-2 inhibition, thereby, causing its constitutive activation. The present study was commenced to elucidate the structural behavior of this mutation in the JM and A-loop region of c-Kit using Molecular Dynamics (MD) simulations of the wild-type and mutant c-Kit in unphosphorylated and phosphorylated states. The energy difference computed between the wild type and mutant (D816V) c-Kit, and protein-protein docking and complex analysis revealed the impact of this single residue mutation on the integrity dynamics of c-Kit that makes it independent of SHP-1/SHP-2 negative regulation.
人们已经对几种调节造血干细胞(HSCs)增殖和自我更新特性的信号通路、配体和基因进行了细致研究。在造血过程中发挥关键作用的信号通路之一是干细胞因子(SCF)介导的c-Kit通路。c-Kit是一种受体酪氨酸激酶(RTK),在包括造血干细胞在内的细胞中表达。它与同源配体SCF结合后会发生二聚化。结果,c-Kit近膜(JM)结构域的酪氨酸568和酪氨酸570残基发生磷酸化。这些磷酸化残基成为蛋白酪氨酸磷酸酶(PTPs)即SHP-1和SHP-2的对接位点,进而导致负责细胞增殖的下游信号去磷酸化和负调控。有趣的是,据报道c-Kit在D816V处的突变使其独立于SCF刺激和SHP-1/SHP-2抑制,从而导致其组成性激活。本研究开始使用野生型和突变型c-Kit在未磷酸化和磷酸化状态下的分子动力学(MD)模拟来阐明c-Kit的JM和A环区域中这种突变的结构行为。野生型和突变型(D816V)c-Kit之间计算出的能量差异以及蛋白质-蛋白质对接和复合物分析揭示了这种单残基突变对c-Kit完整性动力学的影响,使其独立于SHP-1/SHP-2负调控。